STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] ACCURAY INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Accuray Inc. director Robert Kill reported the conversion of 56,603 restricted stock units into common stock on 11/13/2025 at an exercise price of $0 per share. Following this transaction, he beneficially owned 162,809 shares of Accuray common stock directly. The RSUs were originally scheduled to vest 100% on 11/21/2025, but the vesting and settlement into shares were accelerated to 11/13/2025 in connection with his retirement from the Board of Directors.

Positive
  • None.
Negative
  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kill Robert

(Last) (First) (Middle)
1240 DEMING WAY

(Street)
MADISON WI 53717

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ACCURAY INC [ ARAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/13/2025 M 56,603 A $0 162,809 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units(1) $0 11/13/2025 M 56,603 (2) (2) Common Stock 56,603 $0 0 D
Explanation of Responses:
1. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
2. This represents a Restricted Stock Unit that vests 100% on 11/21/2025. Shares have been accelerated to vest on 11/13/2025 in connection with Mr. Kill's retirement from the Board of Directors.
Remarks:
/s/ Michael Stetler, Power of Attorney for Robert Kill 11/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Accuray (ARAY) report for director Robert Kill?

Accuray reported that director Robert Kill converted 56,603 restricted stock units into shares of the company’s common stock on 11/13/2025 at an exercise price of $0 per share.

How many Accuray (ARAY) shares does Robert Kill own after this Form 4 transaction?

After the reported transaction, Robert Kill beneficially owned 162,809 shares of Accuray common stock in direct ownership.

What happened to the 56,603 Accuray (ARAY) restricted stock units reported on the Form 4?

The 56,603 restricted stock units were settled into an equal number of Accuray common shares on 11/13/2025, and the number of those derivative securities outstanding was reduced to 0.

Why were Accuray (ARAY) RSUs scheduled to vest on 11/21/2025 accelerated to 11/13/2025?

The filing states that the RSUs, which were scheduled to vest 100% on 11/21/2025, were accelerated to vest on 11/13/2025 in connection with Mr. Kill's retirement from the Board of Directors.

What type of securities were involved in this Accuray (ARAY) Form 4 filing?

The transaction involved restricted stock units that each represent a contingent right to receive one share of Accuray common stock, which were converted into common shares.

Is the Accuray (ARAY) Form 4 filed for one or multiple reporting persons?

The Form 4 was indicated as being filed by one reporting person, covering the holdings and transactions of director Robert Kill.

Accuray Incorp

NASDAQ:ARAY

ARAY Rankings

ARAY Latest News

ARAY Latest SEC Filings

ARAY Stock Data

117.87M
109.77M
2.06%
71.26%
1.97%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MADISON